A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/167 (2006.01) A61K 31/24 (2006.01) A61K 31/4015 (2006.01) A61K 31/405 (2006.01) A61P 13/00 (2006.01)
Patent
CA 2450467
This invention provides methods and pharmaceutical compositions for maintaining bladder control or treating urinary incontinence in a mammal utilizing agonists of KCNQ potassium channels, including KCNQ2, KCNQ3, KCNQ4 and KCNQ5 potassium channels, alone or in combination. Compounds useful in these methods include the 1,2,4-triamino-benzene derivatives and the substituted 3-phenyl oxindole compounds. Among the preferred compounds of this invention is N-[2-amino-4-(4-fluorobenzylamino)-phenyl]carbamic acid ethyl ester, also referred to as retigabine.
L'invention concerne des méthodes et des compositions pharmaceutiques permettant de maintenir le contrôle de la vessie ou de traiter l'incontinence urinaire chez un mammifère au moyen d'agonistes des canaux potassiques KCNQ, qui comprennent des agonistes des canaux KCNQ2, KCNQ3, KCNQ4 et KCNQ5 utilisés individuellement ou de manière combinée. Les composés convenant pour ces méthodes comprennent les dérivés de 1,2,4-triamino-benzène décrits dans le brevet <= U.S. Patent No. 5,384,330 (Dieter et al.) >= et les composés 3-phényle oxindole décrits dans le brevet <= U.S. Patent No. 5,565,483 (Hewawasam et al.) >=. L'un des composés préférés est l'ester éthylique d'acide N-[2-amino-4-(4-fluorobenzylamino)-phényl]carbamique également connu sous le nom de retigabine .
Argentieri Thomas Michael
Bowlby Mark Robert
Sheldon Jeffrey Howard
Torys Llp
Wyeth
LandOfFree
Methods for modulating bladder function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for modulating bladder function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for modulating bladder function will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1649218